ACSM5 |
acyl-CoA synthetase medium chain family member 5 |
- Conjugation of salicylate with glycine
|
|
|
ASB2 |
ankyrin repeat and SOCS box containing 2 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
ASB8 |
ankyrin repeat and SOCS box containing 8 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
CAPN1 |
calpain 1 |
- Degradation of the extracellular matrix
- Degradation of the extracellular matrix
- Neutrophil degranulation
- Formation of the cornified envelope
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
|
- N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine
- CBZ-LEU-LEU-TYR-CH2F
- (2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE
|
|
CCP110 |
centriolar coiled-coil protein 110 |
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- Ub-specific processing proteases
- AURKA Activation by TPX2
|
|
|
CDR2 |
cerebellar degeneration related protein 2 |
|
|
|
CEBPE |
CCAAT enhancer binding protein epsilon |
- Transcriptional regulation of granulopoiesis
|
|
- Other phagocyte defects, including the following eight diseases: Chediak-Higashi syndrome; Griscelli syndrome, type 1 (GS1); Griscelli syndrome, type 2 (GS2); Griscelli syndrome, type 3 (GS3); beta-actin deficiency; Neutrophil-specific granule deficiency; Myeloperoxidase deficiency; Glucose 6-phosphate dehydrogenase deficiency; Shwachman syndrome
|
DGAT2 |
diacylglycerol O-acyltransferase 2 |
- Acyl chain remodeling of DAG and TAG
- Triglyceride biosynthesis
|
|
|
ELOA |
elongin A |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA Polymerase II Transcription Elongation
|
|
|
ELOA2 |
elongin A2 |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA Polymerase II Transcription Elongation
|
|
|
ELOA3 |
elongin A3 |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA Polymerase II Transcription Elongation
|
|
|
ELOC |
elongin C |
- Formation of RNA Pol II elongation complex
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- Vif-mediated degradation of APOBEC3G
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA Polymerase II Transcription Elongation
- Neddylation
- Regulation of expression of SLITs and ROBOs
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
EPOR |
erythropoietin receptor |
- Signaling by Erythropoietin
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Erythropoietin activates Phospholipase C gamma (PLCG)
- Erythropoietin activates STAT5
- Erythropoietin activates RAS
- Erythropoietin activates RAS
|
- Darbepoetin alfa
- Erythropoietin
- Dibromotyrosine
- Peginesatide
- Methoxy polyethylene glycol-epoetin beta
|
- Congenital polycythemia; Familial erythrocytosis (ECYT)
|
GHR |
growth hormone receptor |
- Prolactin receptor signaling
- Growth hormone receptor signaling
- Growth hormone receptor signaling
|
|
- Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
|
GPS2 |
G protein pathway suppressor 2 |
- PPARA activates gene expression
- HDACs deacetylate histones
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
|
|
|
HOXC10 |
homeobox C10 |
|
|
|
LRRC41 |
leucine rich repeat containing 41 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
PRAME |
preferentially expressed antigen in melanoma |
|
|
|
RACK1 |
receptor for activated C kinase 1 |
- Regulation of TNFR1 signaling
- TNFR1-induced NFkappaB signaling pathway
- TNFR1-mediated ceramide production
|
|
|
RNF7 |
ring finger protein 7 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
SMG1 |
SMG1 nonsense mediated mRNA decay associated PI3K related kinase |
- Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
|
|
|
SOCS1 |
suppressor of cytokine signaling 1 |
- Interleukin-7 signaling
- Regulation of KIT signaling
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- Interleukin-4 and Interleukin-13 signaling
- Interferon gamma signaling
- Regulation of IFNG signaling
- Interferon alpha/beta signaling
- Regulation of IFNA signaling
- Growth hormone receptor signaling
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
SOCS3 |
suppressor of cytokine signaling 3 |
- Interleukin-6 signaling
- Signaling by Leptin
- Interleukin-4 and Interleukin-13 signaling
- Interferon gamma signaling
- Regulation of IFNG signaling
- PTK6 Activates STAT3
- RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
- Neddylation
- Interferon alpha/beta signaling
- Regulation of IFNA signaling
- Growth hormone receptor signaling
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
SOCS6 |
suppressor of cytokine signaling 6 |
- Regulation of KIT signaling
- Neddylation
|
|
|
STC2 |
stanniocalcin 2 |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
USP33 |
ubiquitin specific peptidase 33 |
- Ub-specific processing proteases
- Regulation of expression of SLITs and ROBOs
|
|
|
VHL |
von Hippel-Lindau tumor suppressor |
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- SUMOylation of ubiquitinylation proteins
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
- Renal cell carcinoma
- von Hippel-Lindau syndrome
- Congenital polycythemia; Familial erythrocytosis (ECYT)
|
ZYG11B |
zyg-11 family member B, cell cycle regulator |
|
|
|